Wiener Privatklinik
Multiple sclerosis treatment cost in Austria runs from $200 to $300 for a consultation with an ophthalmologist, while specialized treatments like Ocrevus (ocrelizumab) range from $35,000 to $45,000. Total expenses depend on the disease stage, specific medication protocols, and the need for intensive rehabilitation. Austria offers approximately 20-40% savings compared to the United States. Top cities for MS management include Vienna and Lassnitzhoehe.
Typical Multiple Sclerosis Treatment Costs in Austria
Bookimed Expert Insight: Patients requiring complex therapy benefit from specialists like Professor Fritz Leutmezer at Wiener Privatklinik. His expertise in shaping European MS treatment standards ensures high-level diagnostic accuracy. For intensive recovery, Private Hospital Lassnitzhöhe is ideal. Its ISO-certified neurological rehabilitation facility features 289 beds and an indoor pool. Vienna General Hospital (AKH) offers immense clinical resources with its "city in a city" concept.
| Turkey | Austria | Spain | |
| Plasmapheresis | from $1,200 | from $2,000 | from $1,800 |
| Ocrevus (ocrelizumab) | from $10,000 | from $35,000 | from $25,000 |
| Multiple sclerosis rehabilitation | from $3,000 | from $10,000 | from $10,000 |
| Medication treatment for multiple sclerosis | from $2,500 | from $2,000 | from $3,000 |
| Therapeutic Apheresis | from $1,350 | - | - |
Professor Fritz Leutmezer has contributed to European MS treatment guidelines and led clinical trials shaping modern therapy standards at Wiener Privatklinik.
Dr. Fritz Leutmezer leads Austria's Multiple Sclerosis Society and has published 60+ neurology papers. He treats MS at Vienna General Hospital.
Dr. Natalia Hauser specializes in the diagnosis and treatment of Multiple sclerosis at Döbling Private Hospital.
Dr. Klaus Novak is a neurosurgeon in Vienna with over 20 years of experience. He graduated from the University of Vienna in 1992. He became a board-certified neurosurgeon in 2001. He completed international training. This included research at Beth Israel Hospital in the United States. He introduced intraoperative motor evoked potential monitoring in Austria.
His clinical focus includes spine surgery, brain tumors, hydrocephalus, epilepsy, movement disorders, and neuromodulation. He is active in the interdisciplinary Movement Disorder Board at MedUni Vienna.
Austrian neurologists no longer treat interferon-beta as the exclusive first-line therapy for multiple sclerosis. While still used for stable cases, clinicians now frequently prescribe high-efficacy disease-modifying therapies (DMTs) upfront. This early intensive strategy helps prevent permanent neurological damage in patients with highly active disease.
Bookimed Expert Insight: Data from major Austrian centers like Vienna General Hospital (AKH) and Wiener Privatklinik shows a shift toward university-linked care. Specialists there often serve as university professors. They can access the latest DMTs through clinical trials before they become standard pharmacy stock. Patients diagnosed at these high-volume hubs may receive high-efficacy protocols faster than at smaller regional facilities.
Patient Consensus: Patients note that Austrian doctors prioritize quick diagnostic rounds to start treatment immediately. Many emphasize that while injections are still offered, the option for infusions once or twice yearly is now common.
Certified Multiple Sclerosis centers established by the Austrian Society of Neurology authorize advanced Disease-Modifying Therapies. Leading institutions include Medical University of Vienna and Innsbruck. These centers actively participate in international clinical trials. They monitor long-term safety through the Austrian MS Therapy Registry.
Bookimed Expert Insight: Patient volume impacts clinical expertise in Austria. Vienna General Hospital (AKH) serves 595,000 patients annually. This high volume allows doctors like Dr. Fritz Leutmezer to lead international trials. He has published over 60 scientific papers on neuroinflammatory disorders. Choosing these high-capacity academic centers ensures access to the latest EMA-approved protocols.
Patient Consensus: Patients recommend prioritizing Vienna for the newest treatments and clinical trial opportunities. They suggest using clinicaltrials.gov to find open spots in local studies before they fill up.
Higher-risk multiple sclerosis therapies in Austria require mandatory screening for HIV, hepatitis B/C, and tuberculosis. Patients must confirm varicella zoster virus immunity before starting. Ongoing monitoring includes regular blood counts, liver function tests, and JC virus antibody indexing to manage infection and autoimmunity risks.
Bookimed Expert Insight: Clinical data from Vienna General Hospital (AKH) and Wiener Privatklinik shows that top Austrian neurologists like Dr. Fritz Leutmezer prioritize complex diagnostics. This includes optical coherence tomography and evoked potentials alongside standard bloodwork. Choosing a center with consolidated university research ensures your monitoring aligns with the latest European MS treatment guidelines.
Patient Consensus: Patients note that monitoring fatigue is real due to constant bloodwork. They emphasize that understanding your JC virus index early helps clarify long-term safety protocols.
Patients receiving Disease-Modifying Therapies (DMTs) in Austria typically plan stays from 1 to 14 days. Infusion therapies like Ocrelizumab require a 7-day to 14-day stay for observation. Standard protocols then mandate clinical follow-up every 3 to 6 months to ensure safety and treatment efficacy.
Bookimed Expert Insight: While many plan for a quick trip, Austrian specialists like Dr. Fritz Leutmezer at Wiener Privatklinik often require a 10-day buffer. This timeframe accounts for pre-treatment bloodwork and post-infusion allergy watches. This is crucial because Vienna General Hospital (AKH) serves over 595,000 patients annually, making scheduling flexibility essential for international cases.
Patient Consensus: Patients note it is important to budget an extra week nearby for bloodwork. Some mention that unexpected drops in blood counts can extend stays to 3 weeks.
Patients starting high-efficacy multiple sclerosis immunotherapy in Austria must update vaccinations and screen for chronic infections. Inactivated vaccines require administration 14 days before therapy. Screening for Hepatitis B, Tuberculosis, and HIV is mandatory. Live-attenuated vaccines are contraindicated during active treatment due to safety risks.
Bookimed Expert Insight: Patients at Wiener Privatklinik benefit from protocols led by Dr. Fritz Leutmezer, President of the Austrian Multiple Sclerosis Society. His expertise ensures vaccination schedules align with the latest European MS treatment guidelines. This specialized oversight is critical for managing complex B-cell depleting therapies like Ocrevus (ocrelizumab).
Patient Consensus: Patients emphasize testing for Varicella-Zoster Virus and Hepatitis B immunity immediately. Many note that bringing complete vaccination records to the first neurology visit prevents treatment delays.
Pregnant or nursing women in Austria can continue specific disease-modifying therapies (DMTs) under strict medical supervision. First-line injectables like Interferon-beta and Glatiramer acetate are generally considered safe. Standardized reproductive counseling at MS centers helps manage medication washouts and transition periods to ensure maternal and fetal safety.
Bookimed Expert Insight: Patient volume data highlights Vienna as the primary hub for complex MS care. Vienna General Hospital (AKH) serves 595,000 patients annually. Its neurologist, Dr. Fritz Leutmezer, is the President of the Austrian MS Society and co-authored the national treatment guidelines. Choosing a specialist who literally wrote the reproductive protocols ensures your washout plan aligns with the most recent safety data.
Patient Consensus: Patients emphasize the need for a personalized reproductive roadmap at every visit. Many suggest planning at least 6 months ahead for high-risk DMT transitions and preparing for quick medication restarts after weaning.
Austrian clinics provide specialized international departments to support non-German speakers through multiple sclerosis treatment. Facilities like Wiener Privatklinik offer multilingual environments. Dedicated coordinators manage medical visa documentation, record reviews, and cost estimates. Personal patient managers often bridge the language gap during infusions and recovery.
Bookimed Expert Insight: While large institutions like Vienna General Hospital (AKH) serve 595,000 patients annually, private clinics often provide more direct linguistic support. Wiener Privatklinik and Döbling Private Hospital maintain lower patient volumes to focus on one-on-one coordination. This structure ensures that international patients receive dedicated attention from the 400+ physicians available in these specialized centers.
Patient Consensus: Patients note that while some nurses use basic English, having a translation app or requesting an international coordinator early helps clarify detailed medical forms. Many find that follow-up care is much smoother when using video consultations or dedicated email support from the hospital's international office.